Sonidegib Phosphate Patent Expiration
Sonidegib Phosphate is Used for treating basal cell carcinoma. It was first introduced by Sun Pharmaceutical Industries Ltd
Sonidegib Phosphate Patents
Given below is the list of patents protecting Sonidegib Phosphate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Odomzo | US10266523 | Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4′-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof | Mar 30, 2036 | Sun Pharm |
| Odomzo | US8063043 | Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide | Sep 15, 2029 | Sun Pharm |
| Odomzo | US8178563 | Compounds and compositions as hedgehog pathway modulators | Jul 24, 2029 | Sun Pharm |
Sonidegib Phosphate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List